Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
Clinical trial NCT02166268 · COMPLETED
Trial details
- NCT number
- NCT02166268
- Sponsor
- ALK-Abelló A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.